Journal profile · PHARMACOLOGY & PHARMACY

Future Journal of Pharmaceutical Sciences

ISSN 2314-7245 · eISSN 2314-7253 · SpringerOpen · United Kingdom

Future Journal of Pharmaceutical Sciences: CAS Zone 4 · Medicine (2025 upgraded edition); fully open access; APC about USD 2,190; review about 23 weeks (community reports); 165 articles in 2025; indexed in ESCI.

Impact factor—No published value
CAS zoneZone 4 · Medicine2025 upgraded edition, major category · 2026 Xinrui edition Zone 4 · Medicine
Review timeabout 23 weeksCommunity average
APCUSD 2,190Fully open access
Acceptance—No reports yet
Articles per year1652025 · OpenAlex count

Scope

Aims, scope and focus

Future Journal of Pharmaceutical Sciences is published by SpringerOpen and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Analytical Methods in Pharmaceuticals, Advanced Drug Delivery Systems and Essential Oils and Antimicrobial Activity, together about 23.5% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)

Read the latest articles of Future Journal of Pharmaceutical Sciences at ScienceDirect.com, Elsevier’s leading platform of peer-reviewed scholarly literature

From the journal's Aims & Scope

Research area (LetPub): PHARMACOLOGY & PHARMACY

Main research topics OpenAlex counts of recent articles; shares are approximate

  1. Analytical Methods in PharmaceuticalsChemistry9.9%
  2. Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics7.1%
  3. Essential Oils and Antimicrobial ActivityAgricultural and Biological Sciences6.5%
  4. Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics6.4%
  5. Analytical Chemistry and ChromatographyChemistry6.4%
  6. Computational Drug Discovery MethodsComputer Science5.8%
  7. Phytochemistry and Biological ActivitiesAgricultural and Biological Sciences5.1%
  8. Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics5%

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPharmacology & PharmacyZone 4

Top journal: noReview journal: no

CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
LevelCategoryZone
MajorMedicineZone 4
MinorPharmacology & PharmacyZone 3

Top journal: noReview journal: not marked

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

Database indexing

ESCIDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

h-index
58OpenAlex ·
i10-index
471OpenAlex ·
2-year mean citedness
6.02OpenAlex ·
Self-citation rate
0%LetPub ·
Share of gold OA articles
100%LetPub ·

Volume

Articles per year
164LetPub ·

Articles by year OpenAlex count · 1,083 in total · the current year is incomplete

YearArticlesOpen accessCitations
2026919145
2025165165597
20241781781,972
20231211211,691
202261611,245
20212402405,992

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 23 weeksLetPub ·
Submission to publication (journal-reported)
about 23 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Fully open accessDOAJ

Every article is open access; authors usually pay an article processing charge (APC).

SourceAPCFee waiverLicenseObserved
DOAJEUR 1,890 / USD 2,190 / GBP 1,590YesCC BY
OpenAlexUSD 0——
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Profile

Publication details and official links

Publisher
SpringerOpen
Country or region
United Kingdom
Language
English
ISSN
2314-7245
Electronic ISSN
2314-7253
Official links

FAQ

Frequently asked questions about Future Journal of Pharmaceutical Sciences

What CAS zone is Future Journal of Pharmaceutical Sciences in?

In the 2025 upgraded edition of the CAS Journal Ranking, Future Journal of Pharmaceutical Sciences is in Zone 4 of Medicine, and in Zone 4 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.

How long does peer review take at Future Journal of Pharmaceutical Sciences?

Authors report an average review time of about 23 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Which databases index Future Journal of Pharmaceutical Sciences?

According to LetPub and DOAJ records, Future Journal of Pharmaceutical Sciences is indexed in ESCI and DOAJ.

Is Future Journal of Pharmaceutical Sciences open access, and what is the APC?

Future Journal of Pharmaceutical Sciences is a fully open-access journal. APC about USD 2,190.

Sources and updates

The facts on this page come from LetPub, OpenAlex, DOAJ, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .